SAB Biotherapeutics Inc. (SABS)

NASDAQ: SABS · IEX Real-Time Price · USD
1.94
0.04 (2.11%)
May 26, 2022 4:00 PM EDT - Market closed

Cash Flow Statement (Annual)

Millions USD. Fiscal year is Jan - Dec.
Year202120202019
Net Income
-17.1420.12-8.99
Depreciation & Amortization
1.650.550.32
Share-Based Compensation
2.311.30.37
Other Operating Activities
16.93-11.96-0.92
Operating Cash Flow
3.7610-9.21
Operating Cash Flow Growth
-62.43%--
Capital Expenditures
-10.94-12.72-0.61
Investing Cash Flow
-10.94-12.72-0.61
Share Issuance / Repurchase
34.359.90
Debt Issued / Paid
-0.23-0.92-0.62
Other Financing Activities
004.3
Financing Cash Flow
34.128.983.68
Net Cash Flow
26.936.26-6.14
Free Cash Flow
-7.19-2.72-9.82
Free Cash Flow Margin
-11.80%-4.92%-285.41%
Free Cash Flow Per Share
-0.26-0.11-0.28
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).